| Autor: |
Fasano A; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Canada; Division of Neurology, University of Toronto, Toronto, Canada; Krembil Brain Institute, University Health Network, Toronto, Canada; Center for Advancing Neurotechnological Innovation to Application, Toronto, Canada. Electronic address: alfonso.fasano@uhn.ca., Mure H; Center for Neuromodulation, Department of Neurosurgery, Kurashiki Heisei Hospital, Kurashiki, Japan., Bick SK; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA., Schiess M; Department of Neurology, Movement Disorders and Neurodegenerative Disease Program, McGovern Medical School, University of Texas, Houston, TX, USA., Witt T; Department of Neurosurgery, Indiana University Medical Center, Indianapolis, IN, USA., Kimura K; Department of Neurology, Yokohama City University Medical Center, Kanagawa, Japan., Singer A; Brain Modulation, Neuromodulation Operating Unit, Medtronic PLC, Minneapolis, MN, USA., Sannelli C; Brain Modulation, Neuromodulation Operating Unit, Medtronic PLC, Minneapolis, MN, USA., Morelli N; Brain Modulation, Neuromodulation Operating Unit, Medtronic PLC, Minneapolis, MN, USA., Oyama G; Department of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan. |
| Jazyk: |
angličtina |
| Zdroj: |
Parkinsonism & related disorders [Parkinsonism Relat Disord] 2024 Aug; Vol. 125, pp. 106090. Date of Electronic Publication: 2024 Mar 06. |
| DOI: |
10.1016/j.parkreldis.2024.106090 |
| Abstrakt: |
Competing Interests: Declaration of competing interest AF: Owns stock in Inbrain Pharma; consultancies from Abbvie, Abbott, Boston Scientific, Ceregate, Inbrain, Ipsen, Medtronic, Iota, and Syneos Health; advisory boards for AbbVie, Boston Scientific, Ceregate, Inbrain, Ipsen; honoraria from AbbVie, Abbott, American Academy of Neurology, Boston Scientific, Brainlab, Ipsen, Medtronic, Merz, Movement Disorders Society, Sunovion, Paladin Labs, UCB, Sunovion; royalties from Springer; grants from AbbVie, Boston Scientific, Dystonia Medical Research Foundation, University of Toronto, Michael J FoxFoundation, Medtronic, MSA coalition, Praxis, ES. HM: No conflicts to declare. SKB: Owns stock in TenSixteen Bio; consultancies from Varian Medical Systems; employed by Vanderbilt University Medical Center; grants from National Institute of Health and Department of Defense. MS: Consultancies from Medtronic, Abbott Healthcare, and Treefrog Therapeutic; advisory boards for Medtronic and Treefrog Therapeutics; contracts from Medtronic and Treefrog Therapeutics; grants from National Institute of Health, Michael J FoxFoundation, Medtronic. TW: No conflicts to declare. KK: Honoraria from Medtronic, Boston Scientific, Abbvie, Takeda Pharmaceutical, Ono Pharmaceutical. AS: Employed by Medtronic. CS: Owns stock in Medtronic; employed by Medtronic. NM: Owns stock in Medtronic; employed by Medtronic. GO: Honoraria from Medtronic, Boston Scientific, Abbott Japan LLC Otsuka Pharmaceutical, Co. Ltd., Sumitomo Pharma Co. Ltd., Eisai Co., Ltd., FP pharma, Takeda Pharmaceutical Company LTD., Kyowa Hakko Kirin Co. Ltd., and AbbVie, Inc; grants from Grant from the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C) (#21K12711s). |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect